Purpose of modified thymosin [beta]4 in treatment of radiation enteritis
A radioactive enteritis and thymosin technology, applied in the field of disease treatment, can solve problems such as poor prognosis and large patient injuries
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0040] Example
[0041] In this example, a mouse radiation enteritis model was used to evaluate the effect of modified recombinant human thymosin β4 on the treatment of radiation enteritis.
[0042] 1. Materials and Methods
[0043] 1.1 Drugs:
[0044] Modified recombinant human thymosin β4 (hereinafter referred to as rhG-Tβ4 and rhA-Tβ4), provided by Beijing Northland Biotechnology Co., Ltd., batch number C-20180101 (the sequence is shown in SEQ ID NO: 1) And C-20180315 (the sequence is shown in SEQ ID NO: 2); Specification: 100μg / piece. Use normal saline to make the required concentration before use.
[0045] The natural structure of human thymosin β4 was chemically synthesized by Shanghai Peptix Biotechnology Co., Ltd. (hereinafter referred to as cTβ4), and it was prepared to the required concentration with normal saline before use.
[0046] instrument:
[0047] EG1160 paraffin embedding machine, a product of Leica, Germany;
[0048] RM2255 slicer, a product of Leica, Germany;
[0049...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap